Resverlogix Corp T.RVX

Alternate Symbol(s): RVXCF

Healthcare Biotechnology

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.

TSX:RVX - Post by User

Resverlogix Corp

Bullboard Posts

Comment by BidDogon Feb 16, 2012 12:41pm

269 Views

Post# 19543683

RE: RE: Risky / SanFran

At this point everything that anyone has to offer is of value to me at least.

I'm happy to see this become a more balanced board with various points of view to consider. Your board room experience on the legal side is an asset for sure, I'm guessing that Risky is more of an engineer / scientist / analyst. My background covers a little on both sides - CEO / Engineer .......so I truly appreciate both sides of the equation and I try to understand the value that both sides bring.

Keep it coming.

Bullboard Posts

Unique Battery Metals opportunity in Quebec